SCHEDULE 13G

Company

Spyre Therapeutics, Inc.

Filed

April 18, 2016

Accession Number

0000947871-16-001113

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →